Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03677934 |
|---|---|
| Brief Title: | A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway) |
| First Submitted : | September 11, 2018 |
| First Submitted that Met QC Criteria : | September 18, 2018 |
| First Posted : | September 19, 2018 |
| Results First Submitted : | November 18, 2021 |
| Results First Posted with QC Comments : | December 17, 2021 |
| Results First Submitted that Met QC Criteria : | February 28, 2022 |
| Results First Posted : | March 25, 2022 |
| Certification/Extension First Submitted : | March 24, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | February 28, 2022 |
| Certification/Extension First Posted : | March 25, 2022 |
| Last Update Submitted that Met QC Criteria : | September 6, 2022 |
| Last Update Posted : | October 4, 2022 |